ANTEATERNCT06819865
A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 19 versions: 13 with changes below, 6 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Start date pushed from Aug 30, 2026 to Sep 30, 2026
- Notable Eligibility criteria expanded, about 6 words
- Notable Primary completion pushed from Mar 30, 2027 to May 30, 2028
- Study completion pushed from Jul 30, 2028 to May 30, 2029
- Notable Recruitment opened
- Start date: May 30, 2026 to Aug 30, 2026
- Study sites: 0 to 1
- Notable Start date: Mar 30, 2026 to May 30, 2026v13
Show 7 earlier versionsHide 7 earlier versions
- Notable Start date: Feb 28, 2026 to Mar 30, 2026v11
- Notable Start date: Nov 30, 2025 to Feb 28, 2026v10
- Notable Start date: Aug 30, 2025 to Nov 30, 2025
- Study completion date: Aug 30, 2027 to Jul 30, 2028
- Notable Start date: Jul 30, 2025 to Aug 30, 2025v7
- Notable Start date: Jun 30, 2025 to Jul 30, 2025v6
- Notable Start date: Apr 30, 2025 to Jun 30, 2025v4
- Notable Start date: Mar 30, 2025 to Apr 30, 2025v3
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
RV vs LV end-diastolic diameter ratio
Timeframe: after the completion of EKOS treatment 48 hours compared with the baseline
Secondary (3)
RV vs LV end-diastolic diameter ratio
PE events after the completion of EKOS treatment
Serious adverse events related to EKOS or procedure
Arms and interventions
Single group observational study
To collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Devices: EkoSonicTM Endovascular System
Sites
1 site in 1 country
- The first Affiliated Hospital, Sun Yat-sen UniversityGuangzhou, Guangdong, China